Event Videos

http://www.ncbi.nlm.nih.gov/pubmed/27504812

Valentino PL, Wiggins S, Harney S, Raza R, Lee CK, Jonas MM. J Pediatr Gastroenterol Nutr. 2016 Aug 6

Abstract

OBJECTIVES:
Data regarding pediatric PSC natural history are limited. We describe a large pediatric PSC cohort with longitudinal follow-up.

METHODS:
Records review of pediatric PSC patients diagnosed between 1984 and 2014.

RESULTS:

Published on: 
Aug-2016

http://www.ncbi.nlm.nih.gov/pubmed/27395834

Alam S, Lal B. Indian Pediatr. 2016 Aug 8;53(8):695-701. Epub 2016 Jun 1.

Abstract

CONTEXT:
Suspecting metabolic liver disease in an infant or young child with acute liver failure, and a protocol-based workup for diagnosis is the need of the hour.

EVIDENCE ACQUISITION:
Data over the last 15 years was searched through Pubmed using the keywords Metabolic liver disease and Acute liver failure with emphasis on Indian perspective. Those published in English language where full text was retrievable were included for this review.

RESULTS:

Published on: 
Aug-2016

http://www.ncbi.nlm.nih.gov/pubmed/27569726

Schwimmer JB, Lavine JE, Wilson LA, Neuschwander-Tetri BA, Xanthakos SA, Kohli R, Barlow SE, Vos MB, Karpen SJ, Molleston JP, Whitington PF, Rosenthal P, Jain AK, Murray KF, Brunt EM, Kleiner DE, Van Natta ML, Clark JM, Tonascia J, Doo E; NASH CRN. Gastroenterology. 2016 Aug 25.

Abstract
BACKGROUND & AIMS:
No treatment for nonalcoholic fatty liver disease (NAFLD) has been approved by regulatory agencies. We performed a randomized controlled trial to determine whether 52 weeks of cysteamine bitartrate delayed release (CBDR) reduces the severity of liver disease in children with NAFLD.

METHODS:

Published on: 
Aug-2016

http://www.ncbi.nlm.nih.gov/pubmed/27496798

Narkewicz MR, Horslen S, Belle SH, Rudnick DA, Ng VL, Rosenthal P, Romero R, Loomes KM, Zhang S, Hardison RM, Squires RH; Pediatric Acute Liver Failure Study Group. J Pediatr Gastroenterol Nutr. 2016 Aug 4.

Abstract

OBJECTIVES:
The purpose of this study is to estimate autoantibody (autoAB) frequency, clinical characteristics and 21 day outcome of participants in the Pediatric Acute Liver Failure Study Group (PALFSG) by ANA, SMA and LKM antibody status.

METHODS:
AutoAB were determined at local and/or central laboratories. Subjects were assigned to autoimmune hepatitis (AIH), indeterminate and other diagnoses groups.

RESULTS:

Published on: 
Aug-2016

http://www.ncbi.nlm.nih.gov/pubmed/27482766

.
Srivastava A, Malik R, Bolia R, Yachha SK, Poddar U. J Pediatr Gastroenterol Nutr. 2016 Jul 30.

Abstract

OBJECTIVES:
Pediatric literature on spontaneous bacterial peritonitis (SBP) is limited. We evaluated the prevalence, subtypes, clinical profile and effect on outcome of ascitic fluid infection (AFI) in children with liver disease.

METHODS:
Children with liver disease related ascites and subjected to paracentesis were classified as No-AFI and AFI (SBP, culture negative neutrocytic ascites [CNNA] and monomicrobial non-neutrocytic bacterascites). Clinical and laboratory parameters, in-hospital mortality and outcome in follow-up were noted.

RESULTS:

Published on: 
Jul-2016

http://www.ncbi.nlm.nih.gov/pubmed/27540711

Raizner A, Shillingford N, Mitchell PD, Harney S, Raza R, Serino J, Jonas MM, Lee CK. J Pediatr Gastroenterol Nutr. 2016 Aug 18.

Abstract

OBJECTIVES:
Transient elastography (TE) measures liver stiffness to assess fibrosis. Studies in adults have shown that inflammation increases stiffness, leading to an overestimation of fibrosis. We investigated the contribution of inflammation to liver stiffness measurements (LSM) in children/ young adults.

METHODS:

Published on: 
Aug-2016

http://www.ncbi.nlm.nih.gov/pubmed/27380600

Putignani L, Alisi A, Nobili V. J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S6-8. doi: 10.1097/MPG.0000000000001220

Abstract

PURPOSE OF REVIEW:
Clinical evidence of the use of probiotics in pediatric NAFLD, framed within gut microbiota response, is herein discussed.

RECENT FINDINGS:
The assistance of a new microbiological approach in probiotics' design is playing a central role in NAFLD clinical management. Experimental studies demonstrated the effect of gut microbiota manipulation in NAFLD and recent clinical evidence reported their beneficial effect in pediatric patients.

SUMMARY:

Published on: 
Jul-2016

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: